Dihydralazine

Dihydralazine
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	C02DB01 (WHO) ;
Identifiers
	IUPAC name 4-Hydrazinyl-1-hydrazinylidene-1,2-dihydrophthalazine;
CAS Number	484-23-1 ;
PubChem CID	10230;
ChemSpider	9813 ;
UNII	PCU411F5L6;
KEGG	D07170 ;
ChEMBL	ChEMBL35505 ;
CompTox Dashboard (EPA)	DTXSID0022935 ;
ECHA InfoCard	100.006.914
Chemical and physical data
Formula	C8H10N6
Molar mass	190.210 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES NNc1c2ccccc2C(=NN)Nn1;
	InChI InChI=1S/C8H10N6/c9-11-7-5-3-1-2-4-6(5)8(12-10)14-13-7/h1-4H,9-10H2,(H,11,13)(H,12,14) ; Key:VQKLRVZQQYVIJW-UHFFFAOYSA-N ;
	(what is this?) (verify)

Dihydralazine is a prescription drug with antihypertensive properties. It functions by combating the effects of adrenaline, and by expanding the blood vessels so as to enable smoother flow of blood by decreasing the pressure. It is generally administered orally, and is available in the form of tablets. It belongs to the hydrazinophthalazine chemical class. It has very similar effects to hydralazine.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.